Nuwellis, Inc. (NUWE)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Nuwellis, Inc. (NUWE) is down 92.5% since the beginning of the year. At $0 per share, NUWE is trading 99.5% below its 52-week high of $26. Investors who bought $1,000 worth of NUWE shares 5 years ago would now be looking at an investment worth $0.

Nuwellis, Inc. (NUWE) has returned -92.53% so far this year and -98.84% over the past 12 months. Over the last ten years, NUWE has returned -92.35% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.

Based on dividend-adjusted daily data since Feb 16, 2012, NUWE's average daily return is -0.40%, while the average monthly return is -9.66%.

Historically, 28% of months were positive and 72% were negative. The best month was Jul 2012 with a return of +183.7%, while the worst month was Jun 2026 at -83.2%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 15 months.

On a daily basis, NUWE closed higher 41% of trading days. The best single day was Nov 15, 2017 with a return of +337.7%, while the worst single day was Jun 5, 2026 at -61.2%.

Nuwellis, Inc. has an annualized alpha of -66.32%, beta of 0.60, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since February 16, 2012.

• This stock participated in 276.91% of S&P 500 Index downside but only -168.98% of its upside - more exposed to losses than it benefited from rallies.
• Beta of 0.60 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

NUWE ranks 8 for risk / return — in the bottom 8% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Nuwellis, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Nuwellis, Inc. was 100.00%, occurring on Jun 22, 2026. The portfolio has not yet recovered.

The current Nuwellis, Inc. drawdown is 100.00%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Nuwellis, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Nuwellis, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.